Orchestra BioMed

OBIO

----

Current ValuationThe current P/E ratio is -5.89, below the reasonable range, cheaper than 93.49% of the time in the past 1 years, and the industry ranks 119/173, the industry Median -0.95.

-5.89xP/E

Stock price$5.84Earnings per share$-0.99

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.85x	141.71%	$12.59B
GKOSUSGlaukos	-50.69x	75.37%	$9.53B
TFXUSTeleflex	-5.12x	118.39%	$5.29B
PLSEUSPulse Biosciences	-44.32x	27.55%	$3.55B
IRTCUSIRhythm	-253.36x	70.88%	$3.53B
BFLYUSButterfly Network	-30.95x	34.41%	$2.32B
AXGNUSAxogen	-63.50x	18.38%	$2.13B
ASSTUSStrive	-2.11x	63.23%	$2.06B
NVCRUSNovocure	-11.73x	1.23%	$1.74B
ATECUSAlphatec	-14.80x	41.67%	$1.63B
KMTSUSKestra Medical Tech	-10.60x	0.94%	$1.59B
DRTSUSAlpha Tau Medical	-14.44x	--	$1.34B
TNDMUSTandem Diabetes	-17.76x	77.60%	$1.12B
AORTUSArtivion	-333.70x	266.67%	$1.06B
ENOVUSEnovis	-0.95x	100.97%	$1.05B
IARTUSIntegra LifeSciences	-143.14x	109.42%	$1.04B
PRCTUSPROCEPT BioRobotics	-9.14x	3.47%	$1.00B
BBNXUSBeta Bionics	-13.44x	13.22%	$980.72M
CBLLUSCeribell	-14.15x	35.15%	$934.12M
SIBNUSSI-BONE	-59.88x	8.85%	$876.20M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.